Clinical development
- Pfizer shares Phase 2 trial update to evaluate second-generation candidates against influenza
19 Aug, 2024 - Pipeline Moves: Moderna’s pandemic influenza vaccine trial completes
19 Aug, 2024 - Pfizer, BioNTech give update on mRNA-based combination vaccine programme
19 Aug, 2024 - LVHN participating in potentially groundbreaking pancreatic cancer vaccine trial. What you need to know
19 Aug, 2024 - India working on developing vaccine for dengue
18 Aug, 2024 - Pfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readout
17 Aug, 2024 - There’s a ‘summer surge’ of COVID in Kansas City. See the data & latest on new vaccine
16 Aug, 2024 - Lyme Disease Vaccine Passes Stage Three Trials
16 Aug, 2024 - Bavarian Nordic submits smallpox vaccine data to EMA for extended approval
16 Aug, 2024 - Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency
16 Aug, 2024 - Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
16 Aug, 2024 - Bavarian Nordic asks EU to extend mpox shot license to adolescents
16 Aug, 2024 - China greenlights new mRNA vaccine targeting tumors
16 Aug, 2024 - Tonix Pharmaceuticals Provides Update on the Development of its Single Dose Mpox Vaccine
16 Aug, 2024 - Pfizer Reports Positive Phase 3 Results for RSV Vaccine in Immunocompromised Adults
15 Aug, 2024 - Nasal spray flu vaccine by Madison company boosts protection in seniors, study says
15 Aug, 2024 - Innovative vaccine demonstrates sustained malaria immunisation in pregnancy
15 Aug, 2024 - Vaccine for hepatitis B may allow patients to stop antiviral therapy
15 Aug, 2024 - Malaria vaccine candidate provides lasting protection in trials
15 Aug, 2024 - China’s mRNA tumor vaccine approved for clinical trials
15 Aug, 2024 - CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma
15 Aug, 2024 - French researchers’ hope for individualised cancer vaccines
15 Aug, 2024 - McMaster drug trial receives more than $6m to test smallpox vaccine against mpox
15 Aug, 2024 - In a medical breakthrough, first phase-3 dengue vaccine trial begins in India
15 Aug, 2024 - Dengue vaccine Phase 3 trials begin: Will this be an effective shield?
15 Aug, 2024 - UK health body urges pregnant women to accept new vaccination
15 Aug, 2024 - Breakthrough malaria vaccine offers long-term protection for pregnant women
15 Aug, 2024 - Cutaneous Leishmaniasis Disease Program Advances
15 Aug, 2024 - Twelve years after a terminal prognosis, Maui attorney gives others hope
14 Aug, 2024 - Pediatric RSV nasal vaccine study in Nashville
14 Aug, 2024 - JVC-001 Vaccine Demonstrates Antibody Coverage Against Measles, Mumps, and Rubella
14 Aug, 2024 - Phase three clinical trial of India’s own dengue vaccine, DengiAll, initiated
14 Aug, 2024 - Candidate malaria vaccine provides lasting protection in NIH-sponsored trials
14 Aug, 2024 - ICMR and Panacea Biotec begin first pivotal dengue vaccine trial in India
14 Aug, 2024 - UCLA launches study of personalised cancer vaccine in paediatric brain tumours
14 Aug, 2024 - Cancer patients in Leeds to join personalised vaccine trial
14 Aug, 2024 - Lassa Fever Vaccine Study Supports Advancement to Phase I Trial
14 Aug, 2024 - Bavarian Nordic to test smallpox vaccine for children
13 Aug, 2024 - First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
13 Aug, 2024 - LG Chem to initiate P2 study into infant hexavalent vaccine
13 Aug, 2024 - Pfizer: RSV vaccine generates strong response in immunocompromised adults
13 Aug, 2024 - Vaccination Prevents Most Chikungunya Cases
13 Aug, 2024 - Chikungunya vaccine VLA1553 induces sustained protective antibody concentrations
12 Aug, 2024 - RSV Vaccine Shows Positive Results in Substudy of Phase III Trial of Immunocompromised Patients
12 Aug, 2024 - Recon: FDA denies Lykos MDMA drug; Pfizer reports positive late-stage results for RSV vaccine in immunocompromised adults
12 Aug, 2024 - KEYNOTE-603 Data Further Bolster Merck, Moderna’s Bespoke mRNA Vaccine in NSCLC, Melanoma
12 Aug, 2024 - Pfizer eyes expanded label for RSV vaccine Abrysvo with Phase 3 trial data
12 Aug, 2024
0 Comments